Agency
Moab Valley Healthcare, INC
Moab Valley Healthcare, INC was paid $2.15M by Medicaid between Jan 2018 and Oct 2024, across 53 billing codes. Its largest line is 36415, Collection of venous blood by venipuncture — 44% of everything it billed.
33Billing provider infoMOAB VALLEY HEALTHCARE, INC
MOAB, UT 84532
MOAB, UT 84532
33aNPI1770513236assigned 07/03/2006
33bProvider typeCommunity Based Hospice Care Agency
28Total paid$2.15M
24GClaims33,344
24DCodes billed53
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Community Based Hospice Care Agency providers in Utah
Rank by total paid#13 of 26
Median peer was paid$2.14M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,151 | $216K | |
| 2019 | 4,202 | $242K | |
| 2020 | 5,176 | $399K | |
| 2021 | 9,363 | $588K | |
| 2022 | 8,762 | $638K | |
| 2023 | 665 | $65K | |
| 2024incomplete | 25 | $441.33 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 36415 | Collection of venous blood by venipuncture | 44% | 4,374 | 3,474 | $948K |
| 80053 | Comprehensive metabolic panel | 33% | 3,603 | 2,944 | $701K |
| 81000 | 4.4% | 2,166 | 1,707 | $96K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.8% | 1,218 | 1,085 | $59K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.4% | 2,252 | 1,621 | $51K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 1.7% | 1,559 | 1,290 | $36K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.5% | 361 | 338 | $33K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1.4% | 52 | 46 | $29K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.1% | 262 | 198 | $25K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1.1% | 410 | 345 | $24K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 2,030 | 1,359 | $18K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 292 | 264 | $15K |
41 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 501 | $14K |
| 8888888 | Internal/system code - not a standard HCPCS code | <1% | 45 | $12K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 148 | $10K |
| 99285 | Emergency room visit (most serious) | <1% | 926 | $9K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 504 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 75 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,382 | $7K |
| J3490 | Unclassified drugs | <1% | 39 | $5K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 63 | $5K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 31 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 677 | $4K |
| 80305 | <1% | 258 | $3K | |
| 71045 | Radiologic examination, chest; single view | <1% | 99 | $3K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 915 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 14 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 135 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 980 | $2K |
| 84703 | <1% | 286 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,098 | $2K |
| A9270 | Non-covered item or service | <1% | 62 | $2K |
| 87077 | <1% | 83 | $2K | |
| 87070 | <1% | 28 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 15 | $924.62 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 51 | $744.09 |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 29 | $729.12 |
| 84484 | <1% | 173 | $304.01 | |
| 83605 | <1% | 546 | $301.89 | |
| 80061 | Lipid panel | <1% | 183 | $179.34 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 397 | $165.24 |
| 83690 | <1% | 582 | $163.26 | |
| 83735 | <1% | 358 | $156.91 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 28 | $155.92 |
| 85610 | <1% | 179 | $63.43 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 270 | $39.65 |
| 86140 | <1% | 427 | $35.83 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 60 | $5.45 |
| 96361 | Intravenous infusion, hydration; each additional hour | 0% | 34 | $0.00 |
| 80320 | 0% | 17 | $0.00 | |
| 82150 | 0% | 18 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 15 | $0.00 |
| 87186 | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSADOFF, JENNIFER (CEO)
Parent organizationMOAB VALLEY HEALTHCARE, INC